University of Toronto Faculty of Medicine

PrecisionOS Virtual Reality Anatomy Equally As Effective As Cadavers: New Study Reveals

Retrieved on: 
Wednesday, November 8, 2023
Knowledge, Anatomy, Virtual reality, Attention, Education, Student, Doctor of Philosophy, University, Research, Journal, Software, Learning, Surgeon, Teaching, Orthopedic surgery, Health, University of Toronto Faculty of Medicine, Randomized controlled trial, Nursing, MD, Medicine

Traditionally, the study of anatomy has relied heavily on saw bones or cadaveric specimens, which can present challenges in availability, access, preservation, and ethical considerations.

Key Points: 
  • Traditionally, the study of anatomy has relied heavily on saw bones or cadaveric specimens, which can present challenges in availability, access, preservation, and ethical considerations.
  • PrecisionOS has developed, in concert with surgeons and medical anatomists, a promising alternative through an immersive and interactive 3D virtual reality experience.
  • The PrecisionOS Virtual Reality Anatomy application simulates realistic and anatomically accurate structures, allowing students to explore, disassemble, and learn in a virtual environment.
  • Students initially focused on upper limb anatomy before crossing over to study lower limb anatomy using the alternative educational tool.

Hundreds gather in Toronto to explore how technology can support older adults

Retrieved on: 
Monday, October 16, 2023
Bias, Health, Apathy, University of Toronto Faculty of Medicine, Human–Computer Interaction Institute, Government, University of Virginia Center for Politics, Partner, Equity, Carnegie Mellon University, Caregiver, Ageing, Ageism, Robotics, University, Next Avenue, University Health Network, National Research Council Canada, National Research Council, Social isolation, Intuition, Gold, Conference, Research, Industrial design, Mobile phone, Nursing, Health insurance

By 2035, Canada is expected to be a "super-aged" country with one in four Canadians older than 65 years of age.

Key Points: 
  • By 2035, Canada is expected to be a "super-aged" country with one in four Canadians older than 65 years of age.
  • AgeTech Innovation Week will be the premiere event for technology and innovation for aging and caregiving this year.
  • Hosted by AGE-WELL, Canada's technology and aging network, the week of in-person activities is happening Oct. 23-27, 2023 at the Hilton Toronto.
  • AgeTech Innovation Week brings together stakeholders in research, industry, government and community organizations, older adults, caregivers, future leaders and others committed to enhancing lives through technology.

Expanding Primary Care Access: Schulich Family Medicine Teaching Unit Opens at Humber River Health

Retrieved on: 
Thursday, September 21, 2023
Partnership, University, Schulich, University of Toronto Faculty of Medicine, Family medicine, Physician, Growth, Nursing

The Schulich Family Medicine Teaching Unit is designed to address the critical shortage of primary care providers in Northwest Toronto by providing immediate healthcare access to our community, all while nurturing the next generation of family medicine professionals.

Key Points: 
  • The Schulich Family Medicine Teaching Unit is designed to address the critical shortage of primary care providers in Northwest Toronto by providing immediate healthcare access to our community, all while nurturing the next generation of family medicine professionals.
  • Barb Collins, President and CEO at Humber River Health, expressed her enthusiasm, stating, "The Schulich Family Medicine Teaching Unit is a significant milestone in our ongoing commitment to developing the future of primary care in our community and provides care closer to home.
  • The Schulich Family Medicine Teaching Unit at Humber River Health is poised to make a lasting impact on the healthcare landscape of Northwest Toronto.
  • The Schulich FMTU increases access to comprehensive primary care by offering a variety of interdisciplinary services through the Humber River Family Health Team.

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening

Retrieved on: 
Monday, June 26, 2023
ACT, Faculty, DNA, Commercialization, Communications and Information Technology Commission (Saudi Arabia), UBS AG, Workflow, Survival, Holy Grail, Liquid biopsy, Clinical trial, Cancer, Liver, Global health, Innovation, Genomics, Chinese University of Hong Kong, Mother, Science, University of Hong Kong, Plasma, Death, Chinese, University of Toronto Faculty of Medicine, Royal Medal, CUHK, UBS, Ageing, Lasker, Research, Health, Royal Society, NIPT, Dean (education), Cryptocurrency, Video game, Film industry, Pharmaceutical industry, Vaccine, Cirina, Illumina, Medicine

-- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo.

Key Points: 
  • -- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo.
  • -- By 2030, the early cancer detection screening opportunity is estimated to be US$6bn in Asia on an annual basis.
  • The joint venture will be governed by a six-person board of directors composed of three directors from each side, with Prof.
  • From prevention (CircleDNA) and early detection (Insighta) to treatment (ACT), our innovative approach promises to significantly raise the bar in healthcare."

Registration opens for AgeTech Innovation Week, October 23-27, 2023 in Toronto

Retrieved on: 
Thursday, August 10, 2023
Human–Computer Interaction Institute, University of Toronto Faculty of Medicine, University of Virginia Center for Politics, Partnership, University, National Research Council Canada, NRC, SME, Research, Equity, Government, Register, CAG, Carnegie Mellon University, CFN, Annual general meeting, Health, Bias, Conference, Caregiver, National Research Council, Video game, Nursing, Ageing

TORONTO, Aug. 10, 2023 /CNW/ - Registration is now open for AgeTech Innovation Week , the premiere event for technology and innovation for aging and caregiving this year.

Key Points: 
  • TORONTO, Aug. 10, 2023 /CNW/ - Registration is now open for AgeTech Innovation Week , the premiere event for technology and innovation for aging and caregiving this year.
  • Hosted by AGE-WELL, this unique in-person event is happening October 23-27, 2023 at the Hilton Toronto in Toronto, Canada.
  • AgeTech Innovation Week provides ample opportunities to make connections, whether you are an employer, trainee, researcher, innovator, or looking for an AgeTech partner.
  • Sponsors of AgeTech Innovation Week include the University of Toronto Faculty of Applied Science & Engineering and the National Research Council of Canada.

Wandercraft Partners with a leading Brazilian rehabilitation institution to provide the world's first self-stabilized walking exoskeleton

Retrieved on: 
Thursday, July 13, 2023
Cognition, Faculty, Tetraplegia, Scientific Reports, Brazilian Health Regulatory Agency, Partnership, University, United Nations, ARS, Hospital, Rehabilitation, Disability, Public, Stroke, Quality of life, Post-stroke depression, Atalante, Research, Physical medicine and rehabilitation, Walking, Stoke, Patient, United, Pleasure, Shane Schoeller, Diagnosis, University of Toronto Faculty of Medicine, Health insurance, Medical device, Medicine

NEW YORK, US and PARIS, France, 13 July 2023 -- Wandercraft, the developer of the world's first self-stabilized walking exoskeleton, designed to enable people with walking impairments to stand up and walk again, announced today that it has signed a partnership agreement with the Brazilian Health authority to provide its Atalante X self-stabilized walking exoskeletons to support patient rehabilitation and medical research following a stroke or spinal cord injury. Two Atalante X exoskeletons will be located at Lucy Montoro, a leading Brazilian neurological rehabilitation institution with facilities in and around the city of Sao Paulo.

Key Points: 
  • Two Atalante X exoskeletons will be located at Lucy Montoro, a leading Brazilian neurological rehabilitation institution with facilities in and around the city of Sao Paulo.
  • Atalante X enables individuals with severe gait impairment, including those with upper extremity dysfunction or cognition challenges, to stand up and walk hands-free.
  • The exoskeleton is self-stabilizing for hands-free locomotion and provides multi-directional movement for task-orientated treatment.
  • Users of the Atalante X system may also experience the general health benefits associated with walking, being mobile and upright.

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Retrieved on: 
Thursday, June 29, 2023
Cannabis, Alternative Medicine, Natural Resources, Health, Pharmaceutical, Saskatchewan Order of Merit, Bachelor of Science in Human Biology, University of Toronto Faculty of Medicine, Business development, Cannabis Act, TSX Venture Exchange, University, University of Saskatchewan, Business, Public policy, Crown, Nutrien, Associate, Government, PotashCorp, Organization, Business administration, FAAP, Privatization, Retirement, Acquisition, Division, Hospital, CFO, Knowledge, Entrepreneurship, FRCPC, Chartered Professional Accountant, Health Canada, ICL Group Ltd., Management, Science, SQM, MD, Medicine

ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Wayne Brownlee, former Vice-President and Chief Financial Officer (“CFO”) of both Potash Corporation of Saskatchewan Inc. (“PotashCorp”) and Nutrien Ltd. (“Nutrien”), has agreed to accept an appointment to ZYUS’ Board of Directors.

Key Points: 
  • ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, is pleased to announce that Wayne Brownlee, former Vice-President and Chief Financial Officer (“CFO”) of both Potash Corporation of Saskatchewan Inc. (“PotashCorp”) and Nutrien Ltd. (“Nutrien”), has agreed to accept an appointment to ZYUS’ Board of Directors.
  • Mr. Brownlee brings a wealth of knowledge, experience and expertise to his new role with ZYUS.
  • In 1989, Mr. Brownlee joined PotashCorp when it was a Crown corporation and was a catalyst for the expansion and development throughout its acquisition activity.
  • “We are extremely pleased to welcome Wayne Brownlee to ZYUS’ Board of Directors,” said Brent Zettl, President and Chief Executive Officer of the Company.

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Retrieved on: 
Monday, June 26, 2023
ACT, Faculty, DNA, Commercialization, Communications and Information Technology Commission (Saudi Arabia), UBS AG, Workflow, Survival, Holy Grail, Liquid biopsy, Clinical trial, Cancer, Liver, Global health, Innovation, Genomics, Chinese University of Hong Kong, Mother, Science, University of Hong Kong, Plasma, Chinese, University of Toronto Faculty of Medicine, Royal Medal, Capital, CUHK, UBS, Ageing, Lasker, Research, Health, Royal Society, NIPT, Dean (education), Film industry, Cryptocurrency, Pharmaceutical industry, Medical imaging, Cirina, Illumina, Medicine

Transaction Terms - Prenetics will receive a 50% equity stake, while Prof. Lo’s party will also receive a 50% equity stake.

Key Points: 
  • Transaction Terms - Prenetics will receive a 50% equity stake, while Prof. Lo’s party will also receive a 50% equity stake.
  • The joint venture will be governed by a six-person board of directors composed of three directors from each side, with Prof.
  • Lo, as the Associate Dean (Research) of the Faculty of Medicine at the Chinese University of Hong Kong, consistently demonstrates outstanding academic leadership.
  • Lo published in 20224, will be the technology utilized for multi-cancer early detection screening for Insighta.

Rewiring the brain: More than $25 million to advance Sunnybrook's Harquail Centre for Neuromodulation

Retrieved on: 
Thursday, June 22, 2023
Sunnybrook, Faculty, Deep brain stimulation, Psychiatry, Partnership, Depression, University, Tic disorder, Education, Internal medicine, Engineering, U of T, Research, DSM-IV codes, Hospital, Parkinson's disease, Patient, Post-traumatic stress disorder, University of Toronto Faculty of Applied Science and Engineering, University of Toronto Faculty of Medicine, Health, ALS, Family, Neurology, Alzheimer's disease, Sunnybrook Health Sciences Centre, Pharmaceutical industry, Medical imaging, Management, Medical device, Medicine, Maurice Harquail, Neuromodulation

The gift will also endow a new Harquail Chair in Neuromodulation to be held by the Harquail Centre's director.

Key Points: 
  • The gift will also endow a new Harquail Chair in Neuromodulation to be held by the Harquail Centre's director.
  • "The Harquail family's generous foundational support established the Harquail Centre as a global leader in brain therapy," said Dr. Nir Lipsman, director of the Harquail Centre for Neuromodulation and associate professor of surgery at U of T, who will be the inaugural Harquail Chair in Neuromodulation.
  • In addition to the Harquail family's investment, Sunnybrook Foundation and U of T have committed $3 million and $1 million respectively in matching funds to the Harquail Centre for Neuromodulation.
  • Deeply interdisciplinary in its approach, the Harquail Centre supports a critical mass of experts in surgery, internal medicine, psychiatry, neurology and other fields.

D&A Pharma : Despite the latest alarming figures on alcohol dependence, France is delaying the use of sodium oxybate, which has been prescribed for almost 30 years in Italy and Austria

Retrieved on: 
Thursday, June 22, 2023
Faculty, Sodium oxybate, University, European Medicines Agency, Hope, Tobacco, Death, Patient, University of Toronto Faculty of Medicine, Health, Safety, Pharmaceutical industry, Medicine

The results are alarming: every year in France, alcohol is the cause of 49,000 deaths and an estimated social cost of 118 billion euros.1 Two figures that dramatically sum up the human and financial cost of alcohol dependence, the second leading cause of death after tobacco.

Key Points: 
  • The results are alarming: every year in France, alcohol is the cause of 49,000 deaths and an estimated social cost of 118 billion euros.1 Two figures that dramatically sum up the human and financial cost of alcohol dependence, the second leading cause of death after tobacco.
  • Yet there is a drug whose efficacy has recently been reaffirmed, and which has been prescribed in Italy and Austria for over 30 years to 300,000 patients.
  • Its active ingredient, sodium oxybate, was discovered by French professor Henri Laborit, and is used to help alcohol-dependent people maintaining abstinence.
  • A university thesis on the subject has just been published by the Faculty of Medicine at the University of Amsterdam.